Consideration of Metabolite Efflux in Radiolabelled Choline Kinetics.
choline kinase
efflux
hypoxia
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
12 Aug 2021
12 Aug 2021
Historique:
received:
07
07
2021
revised:
05
08
2021
accepted:
06
08
2021
entrez:
28
8
2021
pubmed:
29
8
2021
medline:
29
8
2021
Statut:
epublish
Résumé
Hypoxia is a complex microenvironmental condition known to regulate choline kinase α (CHKA) activity and choline transport through transcription factor hypoxia-inducible factor-1α (HIF-1α) and, therefore, may confound the uptake of choline radiotracer [
Identifiants
pubmed: 34452207
pii: pharmaceutics13081246
doi: 10.3390/pharmaceutics13081246
pmc: PMC8400349
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical Research Council grant
ID : MR/N020782/1
Organisme : Medical Research Council
ID : MR/N020782/1
Pays : United Kingdom
Organisme : Imperial College NIHR Biomedical Research Centre
ID : WSCC_P62585
Organisme : Imperial College Experimental Cancer Medicines award
ID : C1312/A25149
Organisme : Cancer Research UK
ID : C2536/A10337
Pays : United Kingdom
Références
Braz J Med Biol Res. 2017 Dec 11;51(2):e6373
pubmed: 29267497
Biochim Biophys Acta. 2005 Mar 21;1733(1):53-66
pubmed: 15749057
Nucl Med Biol. 2011 Jan;38(1):39-51
pubmed: 21220128
Cancer Res. 1999 Jan 1;59(1):80-4
pubmed: 9892190
J Cereb Blood Flow Metab. 1985 Dec;5(4):584-90
pubmed: 4055928
Cancer Res. 2004 Jun 15;64(12):4270-6
pubmed: 15205341
Ophthalmic Physiol Opt. 2014 Sep;34(5):502-8
pubmed: 24697967
J Pharmacol Exp Ther. 2015 Sep;354(3):384-93
pubmed: 26148857
PLoS One. 2009 Nov 12;4(11):e7819
pubmed: 19915674
Cancer Res. 2005 Aug 1;65(15):6943-9
pubmed: 16061679
Cancer Res. 2008 Jan 1;68(1):172-80
pubmed: 18172309
Cell. 1994 Jul 1;77(7):1071-81
pubmed: 7912658
Nucl Med Biol. 2006 Nov;33(8):977-84
pubmed: 17127170
Cancer Res. 2006 May 1;66(9):4802-7
pubmed: 16651435
Am J Physiol Endocrinol Metab. 2001 Sep;281(3):E524-36
pubmed: 11500308
J Nucl Med. 1996 Dec;37(12):2049-57
pubmed: 8970533
Hepatology. 2014 Aug;60(2):610-21
pubmed: 24723470
Theranostics. 2020 Jul 9;10(19):8677-8690
pubmed: 32754271
BMC Biol. 2013 Jun 17;11:69
pubmed: 23773777
World J Gastroenterol. 2018 Aug 7;24(29):3222-3238
pubmed: 30090003
Biochem J. 2006 Feb 15;394(Pt 1):325-34
pubmed: 16236026
Nat Rev Drug Discov. 2006 Mar;5(3):219-34
pubmed: 16518375
Toxicol Appl Pharmacol. 2016 Nov 1;310:215-228
pubmed: 27664577
Cancer Res. 2019 Apr 1;79(7):1696-1704
pubmed: 30760520
Essays Biochem. 2011 Sep 7;50(1):209-32
pubmed: 21967059
Adv Exp Med Biol. 2008;614:157-64
pubmed: 18290326
Mol Cancer Ther. 2016 Feb;15(2):323-33
pubmed: 26769123
J Cereb Blood Flow Metab. 2020 Sep;40(9):1769-1777
pubmed: 32663096
Clin Cancer Res. 2011 Dec 15;17(24):7673-83
pubmed: 22038995
BMC Cancer. 2008 Feb 13;8:51
pubmed: 18271955
Cancer Res. 2001 Jan 1;61(1):110-7
pubmed: 11196147
J Lipid Res. 2012 Jan;53(1):149-57
pubmed: 22025560
Cancer Res. 2001 May 1;61(9):3599-603
pubmed: 11325827
Br J Cancer. 2010 May 25;102(11):1555-77
pubmed: 20502460
FASEB J. 2003 Mar;17(3):503-5
pubmed: 12514119
Acta Biochim Biophys Sin (Shanghai). 2007 Sep;39(9):668-74
pubmed: 17805461
Lancet Oncol. 2007 Oct;8(10):889-97
pubmed: 17851129
Oncogene. 2012 Mar 15;31(11):1431-41
pubmed: 21822308
J Nucl Med. 2020 Jun;61(6):827-833
pubmed: 31862801
Nutrients. 2018 Oct 16;10(10):
pubmed: 30332744
Front Physiol. 2014 Jan 08;4:400
pubmed: 24409151
Cancer Sci. 2018 Apr;109(4):944-955
pubmed: 29383798
Circ Res. 2008 May 9;102(9):1075-81
pubmed: 18356544
Cancer Res. 2009 Oct 1;69(19):7721-8
pubmed: 19773436
Oncotarget. 2016 Jun 14;7(24):37103-37120
pubmed: 27206796
Clin Cancer Res. 2009 Sep 1;15(17):5503-10
pubmed: 19706823
Annu Rev Pharmacol Toxicol. 2007;47:731-59
pubmed: 17002597
Clin Cancer Res. 2012 Feb 15;18(4):1063-72
pubmed: 22235095
Medchemcomm. 2013 Apr 1;2013(4):693-696
pubmed: 24976941